InhaleRx Limited (ASX:IRX)
Australia · Delayed Price · Currency is AUD 0.0250
0.00 (0.00%)
Jan 30, 2026, 11:09 AM AEST
InhaleRx Income Statement
Financials in millions AUD. Fiscal year is January - December.
Millions AUD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
Operating Revenue | - | - | - | 0.02 | 0.18 | 0.02 | Upgrade |
Other Revenue | 0.83 | 0.4 | 1.2 | - | - | - | Upgrade |
| 0.83 | 0.4 | 1.2 | 0.02 | 0.18 | 0.02 | Upgrade | |
Revenue Growth (YoY) | -6.39% | -66.63% | 4755.02% | -86.35% | 721.35% | -83.36% | Upgrade |
Cost of Revenue | - | - | - | - | 0.12 | 0.17 | Upgrade |
Gross Profit | 0.83 | 0.4 | 1.2 | 0.02 | 0.07 | -0.15 | Upgrade |
Selling, General & Admin | 0.75 | 1.02 | 1.08 | 0.89 | 0.99 | 0.77 | Upgrade |
Research & Development | 1.44 | 0.62 | 1.45 | 0.98 | 0.12 | 0.2 | Upgrade |
Other Operating Expenses | 0.01 | 0.02 | 0.04 | 0.08 | 0.07 | 0.09 | Upgrade |
Operating Expenses | 2.23 | 1.68 | 2.63 | 1.98 | 1.18 | 1.06 | Upgrade |
Operating Income | -1.4 | -1.28 | -1.42 | -1.95 | -1.11 | -1.21 | Upgrade |
Interest Expense | -0.09 | -0.09 | -0.01 | - | - | - | Upgrade |
Interest & Investment Income | 0 | 0 | 0 | 0.02 | 0 | 0 | Upgrade |
Other Non Operating Income (Expenses) | 0.15 | 0.15 | - | - | - | - | Upgrade |
EBT Excluding Unusual Items | -1.33 | -1.21 | -1.43 | -1.94 | -1.11 | -1.21 | Upgrade |
Gain (Loss) on Sale of Assets | - | - | - | 0.01 | - | - | Upgrade |
Asset Writedown | - | - | -0.01 | - | - | - | Upgrade |
Pretax Income | -1.33 | -1.21 | -1.44 | -1.93 | -1.11 | -1.21 | Upgrade |
Earnings From Continuing Operations | -1.33 | -1.21 | -1.44 | -1.93 | -1.11 | -1.21 | Upgrade |
Net Income | -1.33 | -1.21 | -1.44 | -1.93 | -1.11 | -1.21 | Upgrade |
Net Income to Common | -1.33 | -1.21 | -1.44 | -1.93 | -1.11 | -1.21 | Upgrade |
Shares Outstanding (Basic) | 225 | 213 | 189 | 173 | 168 | 99 | Upgrade |
Shares Outstanding (Diluted) | 225 | 213 | 189 | 173 | 168 | 99 | Upgrade |
Shares Change (YoY) | 18.72% | 12.72% | 9.42% | 3.27% | 68.94% | 27.85% | Upgrade |
EPS (Basic) | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | Upgrade |
EPS (Diluted) | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | Upgrade |
Free Cash Flow | -0.29 | -0.37 | -1.96 | -1.85 | -1.16 | -1.05 | Upgrade |
Free Cash Flow Per Share | -0.00 | -0.00 | -0.01 | -0.01 | -0.01 | -0.01 | Upgrade |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 36.59% | - | Upgrade |
Operating Margin | -167.45% | -318.39% | -118.22% | -7879.43% | -611.57% | -5448.40% | Upgrade |
Profit Margin | -159.03% | -300.98% | -119.87% | -7770.36% | -611.38% | -5447.08% | Upgrade |
Free Cash Flow Margin | -35.19% | -91.78% | -162.94% | -7444.75% | -638.32% | -4741.88% | Upgrade |
EBITDA | - | - | -1.41 | -1.94 | -1.11 | -1.14 | Upgrade |
EBITDA Margin | - | - | -117.42% | - | - | - | Upgrade |
D&A For EBITDA | - | - | 0.01 | 0.01 | 0 | 0.06 | Upgrade |
EBIT | -1.4 | -1.28 | -1.42 | -1.95 | -1.11 | -1.21 | Upgrade |
EBIT Margin | -167.44% | - | -118.22% | - | - | - | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.